Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun;15(3):742-745.
doi: 10.1111/eip.12983. Epub 2020 Jun 1.

Naturalistic conceptions of genetic optimism and precision psychiatry among those at clinical high-risk for psychosis

Affiliations

Naturalistic conceptions of genetic optimism and precision psychiatry among those at clinical high-risk for psychosis

Drew Blasco et al. Early Interv Psychiatry. 2021 Jun.

Abstract

Aim: Fuelled by genomics advances, recent emphasis on the concept of "precision medicine," and public optimism towards genetic advances, it is important to understand how those who are considered to be at clinical high-risk for psychosis (CHR) perceive possible benefits of genetic testing to inform future stakeholder education efforts.

Methods: Semistructured interviews were completed with 20 participants who met CHR criteria. Coding for genetic optimism was completed.

Results: Participants endorsed many conceptualizations of the link between genetics, the development of psychosis, and the benefits of genetic testing. Specifically, themes emerged surrounding how genetic testing may lead to greater genetic knowledge and tailored treatment.

Conclusions: Our results demonstrate that CHR participants generally endorse several precision psychiatry concepts, including how genetic testing may lead to tailored treatment advances. This knowledge may aid development of best communication practices regarding forthcoming genetic advances in diagnosis and treatment among CHR.

Keywords: clinical high-risk; genetic optimism; genetic testing; precision medicine; psychotic disorders.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Statement

Dr. Ragy Girgis reports the following conflicts of interest: 1) received research support from Otsuka, Allergan, BioAdvantex, and Genentech 2) royalties/advance for a book from Routledge/Taylor and Francis.

Dr. Brucato receives royalties for the book The New Evil: Understanding the Emergence of Modern Violent Crime (2019).

References

    1. Austin JC, Smith GN, & Honer WG (2006). The genomic era and perceptions of psychotic disorders: Genetic risk estimation, associations with reproductive decisions and views about predictive testing. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141(8), 926–928. - PubMed
    1. Conrad P (2001). Genetic optimism: Framing genes and mental illness in the news. Culture, Medicine and Psychiatry, 25(2), 225–247. - PubMed
    1. Coors M (2005). Genes in families: Attitudes toward genetic testing for schizophrenia. Schizophrenia Research, 2(72), 271–273. - PubMed
    1. DeLisi LE, & Bertisch H (2006). A preliminary comparison of the hopes of researchers, clinicians, and families for the future ethical use of genetic findings on schizophrenia. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 141(1), 110–115. - PubMed
    1. Fernandes BS, Williams LM, Steiner J, Leboyer M, Carvalho AF, & Berk M (2017). The new field of ‘precision psychiatry’. BMC Medicine, 15(1), 80. - PMC - PubMed

Publication types